Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain

Antimicrob Agents Chemother. 2013 May;57(5):2428-9. doi: 10.1128/AAC.00208-13. Epub 2013 Mar 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acetamides / pharmacology*
  • Adolescent
  • Anti-Bacterial Agents / pharmacology*
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / microbiology
  • Drug Resistance, Bacterial / genetics
  • Female
  • Humans
  • Linezolid
  • Mutation*
  • Oxazolidinones / pharmacology*
  • RNA, Ribosomal, 23S / genetics*
  • Ribosomal Proteins / genetics*
  • Spain
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / genetics*
  • Staphylococcus aureus / isolation & purification

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • RNA, Ribosomal, 23S
  • Ribosomal Proteins
  • ribosomal protein L4
  • Linezolid